Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 06 November 2025

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1729628

Correction: c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity

This article is a correction to:

  1. c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity

    1. Read original article
Parham Jabbarzadeh Kaboli*Parham Jabbarzadeh Kaboli1*Ghazaal RoozitalabGhazaal Roozitalab2Reyhaneh FarghadaniReyhaneh Farghadani3Zoya EskandarianZoya Eskandarian4Abdessamad Zerrouqi*Abdessamad Zerrouqi1*
  • 1Department of Biochemistry, Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland
  • 2Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
  • 3Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya, Selangor Darul Ehsan, Malaysia
  • 4Research Institute Children’s Cancer Center, and Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

A Correction on
c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity

By Jabbarzadeh Kaboli P, Roozitalab G, Farghadani R, Eskandarian Z and Zerrouqi A (2024) Front. Immunol. 15:1498391. doi: 10.3389/fimmu.2024.1498391

An incorrect number was provided for “National Science Centre, Poland”. The correct number is “2020/39/B/NZ6/03513”.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: c-MET, immunotherapy, PD-L1, cancer, galectin, CAR-T, antibody-drug conjugate

Citation: Kaboli PJ, Roozitalab G, Farghadani R, Eskandarian Z and Zerrouqi A (2025) Correction: c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity. Front. Immunol. 16:1729628. doi: 10.3389/fimmu.2025.1729628

Received: 21 October 2025; Accepted: 24 October 2025;
Published: 06 November 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Kaboli, Roozitalab, Farghadani, Eskandarian and Zerrouqi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Parham Jabbarzadeh Kaboli, cGFyaGFtLmthYm9saUB3dW0uZWR1LnBs, cGphYmJhcnphZGVoQGdtYWlsLmNvbQ==; Abdessamad Zerrouqi, YWJkZXNzYW1hZC56ZXJyb3VxaUB3dW0uZWR1LnBs

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.